The purpose of this research study is to determine if a fractional dose of the HPV vaccine produces a detectable immune response. The study will last for one year and involve 4 visits.
Category: Human Papillomavirus (HPV)
Immunity Study
We have identified a genetic marker in people of African descent that could increase the risk of acquiring HIV. The purpose of this study is to find out whether factors in the genital area of the body can change how your body fights HIV.
VIVA Trial
The VIVA Clinical Trial (Vaccine to Interrupt Progression of Vulvar and Anal Neoplasia) will test whether the Human Papillomavirus (HPV) vaccine can improve the health of people who have been previously diagnosed with pre-cancerous lesions.
HSV and HIV Tissue Reservoirs Study
The purpose of this study is to understand whether immune responses to herpes simplex virus type 2 bring HIV infected cells to the genital tract in people with HIV infection. The study will last for 5 months and involve 8 clinic visits.